TikTok content overwhelmingly promotes vaping, putting young users at potential risk of e-cigarette use, according to researchers in Australia. The popular social media platform’s own policies on promoting e-cigarette use are often violated, their new study shows. “Our study explored how e-cigarettes are promoted on TikTok, to assess the effectiveness of the platform’s own ‘drugs,…  read on >  read on >

Black and Hispanic communities in the United States are more often poor — and also more likely to have harmful levels of per- and polyfluoroalkyl substances (PFAS) in their drinking water, a new study reveals. Sources of PFAS pollution — including major manufacturers, airports, military bases, wastewater treatment plants and landfills — are disproportionately sited…  read on >  read on >

Older adults are more easily distracted than younger folks, especially if they’re also physically exerting themselves, according to new research. “Our results suggest that older adults might have heightened distractibility,” said study co-author Lilian Azer, a graduate student from the University of California, Riverside. For the study, the researchers assessed the interaction between physical exertion…  read on >  read on >

Becoming a mother is an experience like no other — a time of joy, anticipation and love. But, for some women, new motherhood can come with challenging emotions. Many women struggle with feelings of sadness, anxiety and overwhelming exhaustion. These emotional struggles, coupled with the physical demands of caring for a newborn, can be signs…  read on >  read on >

There’s a glimmer of good news when it comes to the mental health of America’s adolescents: Visits to U.S. emergency departments for psychiatric troubles declined among kids aged 12 to 17 by the fall of 2022, compared to a year prior. Overall, mean weekly adolescent emergency department (ED) visits for mental health conditions fell by…  read on >  read on >

(HealthDay News) – A gene-targeted personalized vaccine may delay the return of pancreatic cancer according to a small, but promising, trial. The mRNA vaccine, which was tailored to the genetic makeup of each patient’s tumor, worked in half of those who received it during 18 months of follow-up, researchers reported May 10 in the journal…  read on >  read on >